|
Ajani, J A (1997) Treatment of patients with upper gastrointestinal carcinomas. Semin Oncol 24:S19-72-S19-76
|
|
Legha, S S; Gianan, M A; Plager, C et al. (1996) Evaluation of interleukin-2 administered by continuous infusion in patients with metastatic melanoma. Cancer 77:89-96
|
|
Ajani, J A; Ilson, D H; Kelsen, D P (1996) Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas. Semin Oncol 23:55-8
|
|
Perez-Soler, R; Glisson, B S; Lee, J S et al. (1996) Treatment of patients with small-cell lung cancer refractory to etoposide and cisplatin with the topoisomerase I poison topotecan. J Clin Oncol 14:2785-90
|
|
Ajani, J A; Ilson, D H; Kelsen, D P (1995) The activity of paclitaxel in gastrointestinal tumors. Semin Oncol 22:46-50;discussion 51-3
|
|
Daliani, D D; Eisenberg, P D; Weems, J et al. (1995) The results of a phase II randomized trial comparing 5-fluorouracil and 5-fluorouracil plus alpha-interferon: observations on the design of clinical trials for androgen-independent prostate cancer. J Urol 153:1587-91
|
|
Ajani, J A; Ilson, D H; Daugherty, K et al. (1995) Paclitaxel in the treatment of carcinoma of the esophagus. Semin Oncol 22:35-40
|
|
Pazdur, R; Bready, B; Scalzo, A J et al. (1994) Phase II trial of piroxantrone in metastatic gastric adenocarcinoma. Invest New Drugs 12:263-5
|
|
Pazdur, R; Moore, D F; Bready, B et al. (1994) Phase II trial of edatrexate in patients with advanced hepatocellular carcinoma. Ann Oncol 5:646-8
|
|
Moore Jr, D F; Pazdur, R; Abbruzzese, J L et al. (1994) Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma. Ann Oncol 5:286-7
|
Showing the most recent 10 out of 12 publications
